Brevibacillus texasporus BT peptide antibiotic

BT is a group of related peptide antibiotics that are produced by B. texasporus cells in response to nutrient limitation and synthesized by a nonribosomal peptide synthetase; BT1583 is the most abundant isomer; GenBank AY953371

Also Known As:

BT peptide antibiotic, Brevibacillus texasporus; BT peptide antibiotic, B texasporus; BT1583 peptide, B texasporus; TAMUS 2032

Networked: 2 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Oligopeptides: 519
    - Brevibacillus texasporus BT peptide antibiotic: 2

Experts

1.	Jiang, Y W: 2 articles (07/2007 - 12/2005)
2.	Genovese, K J: 1 article (07/2007)
3.	He, H: 1 article (07/2007)
4.	Kogut, M H: 1 article (07/2007)
5.	Li, M A: 1 article (07/2007)
6.	Conway, D P: 1 article (12/2005)
7.	Sims, M D: 1 article (12/2005)

Related Diseases

1.	Weight Gain 12/01/2005 - "At d 42 of study, means for weight gain in the TAMUS 2032 and TAMUS 2032 + MON treatments were greater in comparison with the unmedicated and BMD treatments, and means for feed conversion for both treatments were improved in comparison with the unmedicated treatment. "
2.	Infections 07/01/2007 - "The effects of the BT/TAMUS 2032 cationic peptides on innate immunity and susceptibility of young chickens to extraintestinal Salmonella enterica serovar Enteritidis infection."

Related Drugs and Biologics

1.	Peptides (Polypeptides)